SURGICAL TREATMENT OF PATIENTS WITH COLON CANCER IN DEPARTMENT FOR ABDOMINAL AND GENERAL SURGERY AT MARIBOR GENERAL HOSPITAL IN YEARS 1998–2001
Abstract
Background. The aim of this paper is to present and assess a surgical treatment of patients with colon cancer.
Methods. All patients with colon cancer, who were operated in years 1998–2001, were included in the analysis. We have collected data including patients age, localization and stage of cancer, types of preformed procedures, postoperative mortality, disease recurrence and survival of the patients.
Results. We have operated on 308 patients with histological evidence of colon cancer in abovementioned period. The average patients age was 66.5 years (SD = 11.1; 95% CI: 44.3– 88.7). Primary tumor was most commonly (36%) located in sigmoid colon. UICC stages were as follows: stage I 34 patients, 11%; stage II 141, 46%; stage III 64, 21%; stage IV 69, 22%. We have performed 287 resections of colon (93% resectabillity), of these 214 (75%) were potentially curative R0 resections. Share of urgent procedures was 21%. In the postoperative period 22 patients (7%) have died. Postoperative mortality was significantly higher by urgent (19%) compared to scheduled procedures (4%) ( χ 2 = 16; df = 1; p = 0,005). In the observed time 22% of patients developed recurrent cancer. Mean survival rate of our patients was 1274 days or 3.5 years (SD = 191; 95% CI: 900–1648). Calculated overall five years survival rate was 45%.
Conclusions. Planned and registered surgical treatment of patients with colon cancer, surgical specialization in colon surgery and adjuvant oncological treatment have shown the same incentive results, reflected in increased survival rate.
Downloads
References
Pompe-Kirn V. Epidemiološke značilnosti raka debelega črevesa in danke v Sloveniji. In: Repše S ed. Kirurgija debelega črevesa in danke. Zbornik simpozija. Ljubljana: Katedra za kirurgijo, 1996: 79–85.
Ocvirk J. Rak debelega črevesa in danke. Onkologija 2002; 1: 4–7.
Management of colorectal cancer: a national clinical guideline. Ljubljana: Republic of Slovenia, Ministry of health, 2003: 1–2.
Pompe-Kirn V, Golouh R, Lindtner J et al. eds. Incidenca raka v Sloveniji 1999. Ljubljana: Onkološki inštitut Ljubljana, 2002.
Pompe-Kirn V. Rak v Sloveniji. Dosegljivo na: URL: http://www.onko-i.si/ Slo/Institut/RakVSloveniji.html
Hawk ET, Limburg PJ, Viner JL. Epidemiology and prevention of colorectal cancer. Surg Clin N Am 2002; 82: 905–41.
Repše S, Juvan R, Štor Z. Kirurgija raka debelega črevesa in danke v Sloveniji. Zdrav Vestn 2003; 72: Supll I: 57–60.
Maartense S, Vrancken Peeters MPFM, Spaander PJ, Breslau PJ. Mortality after colon surgery: the value of a mortality registration system. Dig Surg 2003; 20: 316–20.
Repše S ed. Priporočila za celostno obravnavo bolnikov z rakom prebavil. Ljubljana: Ministrstvo za zdravstvo R Slovenije, 1997: 23–32.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
